文献速递冠心病

累及前降支近段的多支血管血运重建后死亡率

Mortality after multivessel revascularisation involving the proximal left anterior descending artery.
PubMed 文献 · Heart · 2022-10-28

该研究为SYNTAX Extended Survival研究的事后分析,纳入1088例三支血管病变患者,按是否累及前降支近段分组,比较PCI与CABG的10年全因死亡和5年MACCE。结果显示前降支近段病变与否未改变PCI与CABG的治疗效应,PCI组5年MACCE均显著高于CABG。

要点

  • 三支血管病变中前降支近段病变与否不影响PCI与CABG的长期治疗效应。
  • PCI组5年MACCE显著高于CABG,无论是否累及前降支近段。
  • SYNTAX Score II 2020可识别前降支近段病变中PCI死亡风险显著更高的患者。

核心结论

  • 在三支血管病变患者中,前降支近段病变的存在与否与PCI或CABG后长期结局的治疗效应无关。

研究设计与样本

  • SYNTAX Extended Survival研究的事后分析,纳入1088例三支血管病变患者,按是否累及前降支近段分组。
  • 评估10年全因死亡和5年主要不良心脑血管事件(MACCE)。

主要发现

  • 559例(51.4%)累及前降支近段,其10年死亡率PCI vs CABG为28.9% vs 21.9%(HR 1.39,95%CI 0.99-1.95)。
  • 未累及前降支近段者10年死亡率PCI vs CABG为28.8% vs 20.2%(HR 1.47,95%CI 1.03-2.09),治疗与亚组交互p=0.837。
  • 5年MACCE在PCI组显著高于CABG:累及前降支近段HR 1.86(95%CI 1.36-2.55),未累及HR 1.54(95%CI 1.11-2.12),交互p=0.408。
  • SYNTAX Score II 2020评估显示,前降支近段病变患者中四分之一PCI死亡风险显著高于CABG,其余四分之三CABG死亡风险相似。

临床怎么用

  • 三支血管病变合并前降支近段病变时,不应仅凭病变位置决定PCI或CABG,需综合评估。
  • 可借助SYNTAX Score II 2020识别PCI死亡风险显著高于CABG的前降支近段病变患者。

局限性

  • 本文为事后分析,结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to investigate whether long-term clinical outcomes differ following percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with three-vessel disease (3VD) and lesions in the proximal left anterior descending artery (P-LAD). METHODS: This post-hoc analysis of the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) Extended Survival study included patients with 3VD who were classified according to the presence or absence of lesions located in the P-LAD. Ten-year all-cause death and 5-year major adverse cardiac or cerebrovascular events (MACCE) were assessed. RESULTS: Among 1088 patients with 3VD, 559 (51.4%) had involvement of P-LAD and their 10-year mortality was numerically higher following PCI versus CABG (28.9% vs 21.9%; HR: 1.39, 95% CI 0.99 to 1.95). Although patients without P-LAD lesions had significantly higher 10-year mortality following PCI compared with CABG, there was no evidence of a treatment-by-subgroup interaction (28.8% vs 20.2%; HR: 1.47, 95% CI 1.03 to 2.09, pinteraction=0.837). The incidence of MACCE at 5 years was significantly higher with PCI than CABG, irrespective of involvement of P-LAD (with P-LAD: HR: 1.86, 95% CI 1.36 to 2.55; without P-LAD: HR: 1.54, 95% CI 1.11 to 2.12; pinteraction=0.408). Individualised assessment using the SYNTAX Score II 2020 established that a quarter of patients with P-LAD lesions had significantly higher mortality with PCI than CABG, whereas in the remaining three-quarters CABG had similar mortality. CONCLUSIONS: Among patients with 3VD, the presence or absence of a P-LAD lesion was not associated with any treatment effect on long-term outcomes following PCI or CABG. TRIAL REGISTRATION NUMBER: SYNTAXES: NCT03417050; SYNTAX: NCT00114972.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Ono M, Hara H, Gao C, et al. Mortality after multivessel revascularisation involving the proximal left anterior descending artery. Heart. 2022. PMID: 35732441. doi:10.1136/heartjnl-2022-320934

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。